Talisman Therapeutics ^Private

Talisman Therapeutics is a stem cell research and development company that is dedicated to revolutionizing the discovery of treatments for Alzheimer's disease. They have developed a novel human stem cell model of Alzheimer's disease, which allows for rapid and relevant compound identification, speeding up the drug discovery process. Their primary goal is to identify novel pharmacological treatments for Alzheimer's disease through their in-house drug discovery program. They also collaborate with other organizations, including large pharmaceutical companies, small biotech businesses, and universities, to maximize the impact of their research and development activities. In addition to developing therapeutics, Talisman provides access to their iPSC platform to support external R&D partnerships.